Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002871 (
anemia
)
52,094
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
STEAP3/
TSAP6
encodes a ferrireductase that is involved in the acquisition of iron by developing erythroblasts and steap3/tsap6 null-mice display severe microcytic anemia. We report a family in which 3 siblings born to healthy parents display transfusion-dependent hypochromic anemia. A nonsense STEAP3/
TSAP6
was identified in the siblings at the heterozygous state. This mutation was inherited from their father while no mutation was found in their mother. A large variability of expression was found between normal alleles in a control population, confirming a previous report that STEAP3/TSAPS6 is an expressed quantitative trait locus (e-QTL). Determination of the relative allele expression showed that the "normal" allele was expressed at a significantly higher level in the father than in the affected siblings relative to the shared mutated allele. The blood level of STEAP3/
TSAP6
mRNA was severely reduced in the siblings, while both parents were in the lower range of normal controls. The STEAP3/
TSAP6
protein was also reduced in lymphocytic cell lines from the patients. Collectively, our data support the hypothesis that STEAP3/
TSAP6
deficiency leads to severe
anemia
in the affected siblings and results from the combination of a mutated allele inherited from their father and a weakly expressed allele inherited from their mother.
...
PMID:A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. 2203 63
Genetic ablation of the ferrireductase STEAP3, also known as
TSAP6
, leads to severe microcytic and hypochromic red cells with moderate
anemia
in the mouse. However, the mechanism leading to
anemia
is poorly understood. Previous results indicate that
TSAP6
/Steap3 is a regulator of exosome secretion. Using
TSAP6
/Steap3 knockout mice, we first undertook a comprehensive hematologic characterization of the red cell compartment, and confirmed a dramatic decrease in the volume and hemoglobin content of these erythrocytes. We observed marked anisocytosis as well as the presence of fragmenting erythrocytes. Consistent with these observations, we found by ektacytometry decreased membrane mechanical stability of knockout red cells. However, we were unable to document significant changes in the expression levels of the major skeletal and transmembrane proteins to account for this decrease in the membrane stability. Furthermore, there were no differences in red cell survival between wild type and knockout animals. However, when we monitored erythropoiesis, we found a decreased number of proerythroblasts in the bone marrow of
TSAP6
/Steap3(-/-) animals. In addition, progression from the proerythroblastic to the orthochromatic stage was affected, with accumulation of cells at the polychromatic stage. Altogether, our findings demonstrate that abnormal erythroid maturation is the main cause of
anemia
in these mice.
...
PMID:Abnormal erythroid maturation leads to microcytic anemia in the TSAP6/Steap3 null mouse model. 2551 17